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Abstract. The aim of this study was development of a HPLC method for the separation and 
determination of isoniazid in rat plasma on a Waters e 2695 liquid chromatograph and detection in 
UV at 270 nm, equiped with a Luna 100-10 C18 (250 x 4.6 mm) column and a mobile phase 
formed by a mixture of methanol / buffer acetate pH=5.0 (20 / 80) at a flow of 1.0 ml/min. The 
method shows a good liniarity in the range of 0.02 – 10 µg/ml isoniazide, values of correlation 
coefficient r = 0.9997 . 
  




The isoniazide presents an elective action towards the “Mycobacterium tuberculosis”, 
bacteriostatically at concentrations of 0.01 – 0.05 µg/mL and bacterially at 10.5 µg/mL, only active 
on bacilli in the condition of logarithmic multiplication. The association with other tuberculostats 
reduces frequency and delays resistance. [1,2] 
Considering the importance of isoniazide in therapeutics [2,7],  we decided to elaborate and validate 
a method for the separation and identification through high performance liquid chromatography of  
isoniazid in plasma rat. The drug metabolism of isoniazid is unusually complicated in that it is a  





Figure 1. Isoniazid  metabolism 
 
 
MATERIAL AND METHOD 
1. Materials 
 -reference substances: Isoniazide (CRS ) according to the European Pharmacopoeia  [7]. 
- HPLC purity Metanol (Merck) 
- Ammonium acetate (Merck) 
-Acetate copper II (Merck) 
- Isoniazide- tablets 100mg (Antibiotice SA Iaşi) 
- Milli-Q water (18,2 MΩ/cm resistivity) 
2. Equipment 
- HPLC Waters 2695 with UV-Waters 2489 detector 
- Empower® software data acquisition and processing programme 
-Balance AB54S (Metter-Toledo) 
- Centrifuge 2-15 Sigma 
 
3. Chromatographic conditions: 
- Luna 100-5 C18 chromatographic column, 250 x 4,6 mm, (Phenomenex) lot:5291-77 
- UV detection at a 270 nm wavelength 
-Mobile phase: methanol / acetate buffer pH= 5.0 (ammonium acetate 50g/L, 0.2g/L acetate copper 
II)   for an 20 / 80 report 
- 1 mL/min flow 
- 20 µL volume of injected solution 
- Column temperature = 25° C 
- Sample temperature = 4°C 
Blood sample:  
Doses were established depending on the linearity of pharmacokinetic parameters in rat and 
the necessary conditions requested by the analytical method 5 mg/kg, oral administration, 
corespunding to a dose of 1 mg/animal weighing about 200g). [2]. 
After administration, before each blood prelevation, animal anaesthesia was induced  with 
ethylic ether, which is not metabolised in the rat organism: it is not soluble in plasma or bound by 
plasmatic proteins and also does not cause interferences with other metabolic processes. Right after 
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prelevation, blood samples were transferred in tubes and centrifuget at 3000 rotations/minute for 10 
minutes. 0.5 ml plasma samples were deproteinized with 0.5 ml isoamilic alcool and centrifuget at 
4000 rotations/ minute [ 3, 4].  
Stock and working solutions: 
- stock solution Isoniazide in water:methanol = 50:50 (v:v) 1000 µg/ml 
- for plasma spikind -8 working solutions of Isoniazide in methanol:water = 50:50 (v:v) were 
prepared, having the following concentrations: 0.2 ; 0.5; 1; 5;10; 50;80;100 µg/ml. 
Plasma calibration standards and control samples preparation: 
Plasma standard solution  concentrations for the calibration curve were: 0.02; 0.05; 0.1; 0.5; 1; 4; 7; 
10 µg/ml. Plasma control samples concentrations (QC) were 0.06; 5; 8 µg/ml Isoniazide [3, 4,6].. 
 
RESULTS AND DISCUSSIONS 
 
The selectivity of the method was determined by injecting the following solutions: 
- solvent,  
- standard solutions 
- test solutions. 
Admissibility criteria: the absence of peaks from the solvent that might interfere with the 
peak of the isoniazide from the chromatography obtained with the standard solution, respectively 
















The method proved to be linear between 0.020-10.00 µg/mL Isoniazide, with a typical calibration 
curve , N=8 calibration point, were prepared by diluting a stock solution. Each solution was injected 
3 times. The calibration curve obtained for coefficient linearity interval, has a correlation coefficient 
R² =0.9997. [4,5]. 
 
Rat plasma samples analysis: 
Rat plasma samples were analysed in one series, together with standard calibration and six control 
samples, two at each concentration level. Injection sequence was validated, calibration curve being 
valid ( correlation coefficient =0.9997) and QC samples in limits of 15% (Table I) 
 
Table I. 
QC samples analysis 
C (µg/ml) 0.06 0.06 5.00 5.00 8.00 8.00 
Cf Isoniazide 
(µg/ml) 
0.051 0.056 4.75 4.65 8.30 7.50 
Er % 15.00 6.70 5.00 7.00 3.75 6.25 
 
Er %- relative error 





- The chromatograms of the solvent do not have answers that could interfere with the determination 
of the isoniazide in the standard solution.  
- The processing of the test is simple and fast 
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